You are viewing the public part of the archive. Login or request access to view more content.

Displaying 1-6 of 6 results
first frame of video
00:05:09

2012_41

XIX International AIDS Conference. Interview with Gregg Alton from the Gilead Sciences, Inc. a pharmaceutical company working with health care services, policy makers, etc. to develop effective treatment, treatment as prevention and promoting access to care.

2012_41

first frame of video
01:43:46

2012_27

XIX International AIDS Conference. Session on Pediatrics with medical doctors and scientists discussing prevention of mother-to-child transmission and the development of antiretroviral treatments suitable for infants and small children.

2012_27

first frame of video
00:31:21

2012_20

XIX International AIDS Conference in Washington D.C. Dr. Gottfried Hirnschall, Director of the Department of HIV and Global Hepatitis Programme of WHO, speaks at the plenary session Expanding HIV Testing and Treatment Globally.

2012_20

first frame of video
00:26:40

2006_13_03

Last part of the interview with the American AIDS activist and founder of Project Inform, Martin Delaney, in 2006. Here he talks about AIDS activism and the different stages of the antiretroviral drug development from AZT to triple combination treatment.

2006_13_03

first frame of video
00:14:53

2003_11_01

Interview with Pathologist Christian Isichei, founder of the Faith Alive Hospital in Jos in Nigeria. He talks about the drug industry and access to ARV treatment in Africa and his experiences from the annual conference at the Institute of Human Virology (IHV) in Baltimore.

2003_11_01

first frame of video
00:29:28

2002_8_04

Lars Olof Kallings talks about the global AIDS situation and what the international community can do. He reflects on the role of men, women and young people in the fight against AIDS, and stresses the importance of activists and voluntary organizations.

2002_8_04